UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study

International journal of radiation oncology, biology, physics, 2016-11, Vol.96 (4), p.759-769

2016

Link zum Volltext

Verfügbarkeit prüfen

Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial

International journal of radiation oncology, biology, physics, 2018-12, Vol.102 (5), p.1420-1429

2018

Link zum Volltext

Verfügbarkeit prüfen

70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial

International journal of radiation oncology, biology, physics, 2011-07, Vol.80 (4), p.1056-1063

2011

Link zum Volltext

Verfügbarkeit prüfen

Combined Proton and Photon Conformal Radiotherapy for Intracranial Atypical and Malignant Meningioma

International journal of radiation oncology, biology, physics, 2009-10, Vol.75 (2), p.399-406

2009

Link zum Volltext

Verfügbarkeit prüfen

Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004–03

Radiotherapy and oncology, 2012-04, Vol.103 (1), p.57-62

2012

Link zum Volltext

Verfügbarkeit prüfen

Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO)

PloS one, 2017-11, Vol.12 (11), p.e0187794-e0187794

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of electromagnetic transmitter and ultrasound imaging for intrafraction monitoring of prostate radiotherapy

Radiotherapy and oncology, 2019-07, Vol.136, p.1-8

2019

Link zum Volltext

Verfügbarkeit prüfen

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Preliminary Results of GETUG-01

Journal of clinical oncology, 2007-12, Vol.25 (34), p.5366-5373

2007

Link zum Volltext

Verfügbarkeit prüfen

Resident training in brachytherapy in France: A 10-year update after the first survey of SFJRO members

Journal of contemporary brachytherapy, 2022-12, Vol.14 (6), p.501-511

2022

Link zum Volltext

Verfügbarkeit prüfen

A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial

European urology open science (Online), 2023-08, Vol.54, p.80-87

2023

Link zum Volltext

Verfügbarkeit prüfen

Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers

Cancers, 2020-12, Vol.13 (1), p.57

2020

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Hypofractionated Radiation Therapy for Noncompressive Vertebral Metastases in Combination With Zoledronate: A Phase 1 Study

International journal of radiation oncology, biology, physics, 2016-11, Vol.96 (4), p.840-847

2016

Link zum Volltext

Verfügbarkeit prüfen

Brachytherapy versus prostatectomy in localized prostate cancer: Results of a French multicenter prospective medico-economic study

International journal of radiation oncology, biology, physics, 2007-03, Vol.67 (3), p.812-822

2007

Link zum Volltext

Verfügbarkeit prüfen

Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study

Frontiers in oncology, 2022-01, Vol.11, p.781121

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost Analysis of Complex Radiation Therapy for Patients With Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2016-06, Vol.95 (2), p.654-662

2016

Link zum Volltext

Verfügbarkeit prüfen

Cost of prostate image-guided radiation therapy: Results of a randomized trial

Radiotherapy and oncology, 2013, Vol.106 (1), p.50-58

2013

Link zum Volltext

Verfügbarkeit prüfen

Combined intra-cavitary and interstitial image-guided adaptative brachytherapy for cervical stump carcinomas: technical and clinical results of six patients

Journal of contemporary brachytherapy, 2022-01, Vol.14 (3), p.248-252

2022

Link zum Volltext

Verfügbarkeit prüfen

Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free survival

Journal of contemporary brachytherapy, 2021-08, Vol.13 (4), p.373-386

2021

Link zum Volltext

Verfügbarkeit prüfen

Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer

Clinical and translational radiation oncology, 2024-01, Vol.44, p.100702-100702, Article 100702

2024

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol

Clinical and translational radiation oncology, 2023-05, Vol.40, p.100613-100613, Article 100613

2023

Link zum Volltext

Verfügbarkeit prüfen

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy

Advances in radiation oncology, 2021-07, Vol.6 (4), p.100694, Article 100694

2021

Link zum Volltext

Verfügbarkeit prüfen

Salvage brachytherapy with or without external beam radiotherapy for oral or oropharyngeal squamous cell carcinomas in previously irradiated areas: carcinologic and toxicity outcomes of 25 patients

Journal of contemporary brachytherapy, 2021-01, Vol.13 (4), p.402-409

2021

Link zum Volltext

Verfügbarkeit prüfen

Long term results of the NRG/RTOG 9413: a key study but one of the most confusing study in prostate cancer radiotherapy

Translational andrology and urology, 2019-07, Vol.8 (Suppl 3), p.S257-S260

Pommier, Pascal

2019

Link zum Volltext

Verfügbarkeit prüfen

Does short-term androgen depletion add to high dose radiotherapy (80 Gy) in localized intermediate risk prostate cancer? Final analysis of GETUG 14 randomized trial (EU-20503/NCT00104741)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.5021-5021

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 204

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(195)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(126)
Life Sciences & Biomedicine
(118)
Humans
(92)
Oncology
(72)
Male
(69)
Radiology, Nuclear Medicine & Medical Imaging
(57)
Life Sciences
(55)
Aged
(46)
Middle Aged
(41)
Female
(38)
Radiotherapy
(32)
Adult
(30)
Prostatic Neoplasms - Radiotherapy
(25)
Prostate Cancer
(24)
Cancer
(23)
Hematology, Oncology And Palliative Medicine
(21)
Prospective Studies
(20)
Brachytherapy
(19)
Radiation Therapy
(19)
Radiotherapy Dosage
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study

Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial

70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial

Combined Proton and Photon Conformal Radiotherapy for Intracranial Atypical and Malignant Meningioma

Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004–03

Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO)

Comparison of electromagnetic transmitter and ultrasound imaging for intrafraction monitoring of prostate radiotherapy

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Preliminary Results of GETUG-01

A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial

Resident training in brachytherapy in France: A 10-year update after the first survey of SFJRO members

A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial

Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers

High-Dose Hypofractionated Radiation Therapy for Noncompressive Vertebral Metastases in Combination With Zoledronate: A Phase 1 Study

Brachytherapy versus prostatectomy in localized prostate cancer: Results of a French multicenter prospective medico-economic study

Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study

Cost Analysis of Complex Radiation Therapy for Patients With Head and Neck Cancer

Cost of prostate image-guided radiation therapy: Results of a randomized trial

Combined intra-cavitary and interstitial image-guided adaptative brachytherapy for cervical stump carcinomas: technical and clinical results of six patients

Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free survival

Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer

Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy

Salvage brachytherapy with or without external beam radiotherapy for oral or oropharyngeal squamous cell carcinomas in previously irradiated areas: carcinologic and toxicity outcomes of 25 patients

Long term results of the NRG/RTOG 9413: a key study but one of the most confusing study in prostate cancer radiotherapy

Does short-term androgen depletion add to high dose radiotherapy (80 Gy) in localized intermediate risk prostate cancer? Final analysis of GETUG 14 randomized trial (EU-20503/NCT00104741)

Suchergebnisse filtern